Sudarshan Pharma rises from ₹27 to ₹35.60, up over 30% YTD
In short
Sudarshan Pharma shares have risen from ₹27 to ₹35.60, giving investors more than 30% returns so far in 2026.
The stock has moved up strongly, but the report does not say what caused the rise. It also does not say whether the shares can keep going higher after profit-taking.
What the reporting says
Sudarshan Pharma shares climbed from ₹27 to ₹35.60, giving shareholders more than 30% year-to-date returns. The publisher summary does not mention any corporate announcement, earnings update, or catalyst for the move. What remains unclear is whether the gain can continue after profit-booking pressure, which the headline raises but the source does not quantify.
Why it matters
Sudarshan Pharma shares moved up from ₹27 to ₹35.60, delivering more than 30% year-to-date returns. The publisher summary gives the price change but no corporate event, earnings trigger, or other reason. The market impact is positive for existing shareholders, though the source leaves the sustainability of the rally unknown.